In a clinical trial called SURMOUNT-5, people who used Zepbound over 72 weeks lost 20.2% of their body weight, compared to 13.7% in people who used Wegovy
p38 MAPK, mitogen-activated protein kinases
Clinical data revealed that beta-cell function had partly recovered from diagnosis to study inclusion in participants with well-regulated SIDD but remained low in those who were dysregulated
NCBI However, Wegovy and Ozempic are not approved for exactly the same conditions: Ozempic (semaglutide injection) is FDA-approved for adults with type 2 diabetes to: Improve blood sugar control, and Reduce the risk of major cardiovascular events (heart attack, stroke, or cardiovascular death) in adults with type 2 diabetes and established cardiovascular disease
Padan E, Cohen Y (1982) Anoxygenic Photosynthesis
Understanding these distinctions helps clarify which approach aligns with your health needs and budget